Nuveen LLC Purchases New Position in Teladoc Health, Inc. $TDOC

Nuveen LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor purchased 1,481,018 shares of the health services provider’s stock, valued at approximately $11,789,000. Nuveen LLC owned approximately 0.84% of Teladoc Health at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Cambridge Investment Research Advisors Inc. increased its holdings in Teladoc Health by 60.8% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider’s stock valued at $316,000 after purchasing an additional 15,030 shares in the last quarter. Golden State Wealth Management LLC increased its holdings in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 1,690 shares in the last quarter. Wedmont Private Capital increased its holdings in Teladoc Health by 20.3% in the 1st quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider’s stock valued at $117,000 after purchasing an additional 2,715 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its holdings in Teladoc Health by 22.1% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider’s stock valued at $134,000 after purchasing an additional 2,662 shares in the last quarter. Finally, Vontobel Holding Ltd. increased its holdings in Teladoc Health by 61.4% in the 1st quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider’s stock valued at $171,000 after purchasing an additional 8,152 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

TDOC has been the topic of a number of analyst reports. Stifel Nicolaus dropped their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research report on Thursday, May 1st. Canaccord Genuity Group reduced their price target on Teladoc Health from $14.00 to $12.00 and set a “buy” rating for the company in a report on Thursday, May 1st. Citigroup reduced their price target on Teladoc Health from $11.00 to $8.75 and set a “neutral” rating for the company in a report on Friday, April 25th. Bank of America reduced their price target on Teladoc Health from $8.00 to $7.00 and set a “neutral” rating for the company in a report on Wednesday, May 28th. Finally, Wells Fargo & Company reduced their price target on Teladoc Health from $10.00 to $8.00 and set an “equal weight” rating for the company in a report on Thursday, May 8th. Six research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to MarketBeat, Teladoc Health has a consensus rating of “Hold” and a consensus price target of $9.75.

Insider Buying and Selling

In related news, insider Adam C. Vandervoort sold 5,808 shares of Teladoc Health stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $39,842.88. Following the completion of the transaction, the insider directly owned 69,773 shares in the company, valued at approximately $478,642.78. This trade represents a 7.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Carlos Nueno sold 3,958 shares of Teladoc Health stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.86, for a total value of $27,151.88. Following the completion of the transaction, the insider owned 17,645 shares of the company’s stock, valued at $121,044.70. This trade represents a 18.32% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 18,656 shares of company stock worth $128,189. Corporate insiders own 0.58% of the company’s stock.

Teladoc Health Stock Up 6.7%

NYSE:TDOC opened at $7.6740 on Friday. The company has a market capitalization of $1.36 billion, a price-to-earnings ratio of -6.45 and a beta of 1.76. Teladoc Health, Inc. has a one year low of $6.35 and a one year high of $15.21. The stock has a 50-day simple moving average of $7.73 and a 200 day simple moving average of $8.22. The company has a debt-to-equity ratio of 0.70, a quick ratio of 2.58 and a current ratio of 2.67.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Tuesday, July 29th. The health services provider reported ($0.19) EPS for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.08. The business had revenue of $631.90 million during the quarter, compared to the consensus estimate of $621.91 million. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The company’s revenue for the quarter was down 1.6% compared to the same quarter last year. During the same period last year, the firm earned ($0.38) earnings per share. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. Sell-side analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.